BrainStorm Cell Therapeutics
BCLI
#10412
Rank
A$8.89 M
Marketcap
A$0.81
Share price
-3.57%
Change (1 day)
-75.44%
Change (1 year)

BrainStorm Cell Therapeutics (BCLI) - Cash on Hand

Cash on Hand as of September 2025 : A$0 Million

According to BrainStorm Cell Therapeutics's latest financial reports the company has A$0 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

BrainStorm Cell Therapeutics - Cash on Hand chart (from 2002 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31A$0.3 M-84.24%
2023-12-31A$1.9 M-56.47%
2022-12-31A$4.38 M-85.62%
2021-12-31A$30.47 M-44.12%
2020-12-31A$54.53 M6610.78%
2019-12-31A$0.81 M-91.9%
2018-12-31A$10.02 M0.93%
2017-12-31A$9.93 M-28.32%
2016-12-31A$13.85 M-36.72%
2015-12-31A$21.9 M109.86%
2014-12-31A$10.43 M165.74%
2013-12-31A$3.92 M-0.12%
2012-12-31A$3.93 M109.65%
2011-12-31A$1.87 M1948.44%
2010-12-31A$0.09 M8124.55%
2009-12-31A$0 M-60.73%
2008-12-31A$0 M-97.12%
2007-12-31A$0.09 M29.24%
2006-12-31A$0.07 M
2006-03-31A$0.41 M-39.65%
2005-03-31A$0.68 M11050.5%
2004-03-31A$0 M-63.12%
2003-03-31A$0.01 M-75.54%
2002-03-31A$0.06 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Gilead Sciences
GILD
A$10.96 B 146,979,900.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
A$1.43 B 19,250,600.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
A$1.84 B 24,739,700.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
A$5.91 B 79,207,900.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
A$5.16 M 69,060.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA